Chitty, JL, Yam, M, Perryman, L, Parker, AL, Skhinas, JN, Setargew, YFI, Mok, ETY, Tran, E, Grant, RD, Latham, SL, Pereira, BA, Ritchie, SC, Murphy, KJ, Trpceski, M, Findlay, AD, Melenec, P, Filipe, EC, Nadalini, A, Velayuthar, S, Major, G, Wyllie, K, Papanicolaou, M, Ratnaseelan, S, Phillips, PA, Sharbeen, G, Youkhana, J, Russo, A, Blackwell, A, Hastings, JF, Lucas, MC, Chambers, CR, Reed, DA, Stoehr, J, Vennin, C, Pidsley, R, Zaratzian, A, Da Silva, AM, Tayao, M, Charlton, B, Herrmann, D, Nobis, M, Clark, SJ, Biankin, AV, Johns, AL, Croucher, DR, Nagrial, A, Gill, AJ, Grimmond, SM, Chantrill, LA, Chou, A, Dwarte, T, Metcalf, XL, Jeong, G, Kenyon, L, Waddell, N, Pearson, JV, Patch, AM, Nones, K, Newell, F, Mukhopadhyay, P, Addala, V, Kazakoff, S, Holmes, O, Leonard, C, Wood, S, Hofmann, O, Samra, JS, Pavlakis, N, Arena, J, High, HA, Asghari, R
, Merrett, ND, Das, A, Cosman, PH, Ismail, K, Stoita, A, Williams, D, Spigellman, A, McLeo, D, Kirk, J, Kench, JG, Grimison, P, Sandroussi, C, Goodwin, A, Mead, RS, Tucker, K, Andrews, L, Texler, M, Forrest, C, Ballal, M, Fletcher, D, Beilin, M, Feeney, K, Epari, K, Mukhedkar, S, Zeps, N, Nguyen, NQ, Ruszkiewicz, AR, Worthley, C, Chen, J, Brooke-Smith, ME, Papangelis, V, Clouston, AD, Barbour, AP, O’Rourke, TJ, Fawcett, JW, Slater, K, Hatzifotis, M, Hodgkinson, P, Nikfarjam, M, Eshleman, JR, Hruban, RH, Wolfgang, CL, Scarpa, A, Lawlor, RT, Corbo, V, Bassi, C, Jamieson, NB, Chang, DK, Dreyer, SB, Abdulkhalek, L, Schmitz, T, Lee, V, Stewart, KP, Arshi, M, Steinmann, AM, Pajic, M, Timpson, P, Jarolimek, W & Cox, TR 2023, '
A first-in-class pan-lysyl oxidase inhibitor impairs stromal remodeling and enhances gemcitabine response and survival in pancreatic cancer',
Nature Cancer, vol. 4, no. 9, pp. 1326-1344.
https://doi.org/10.1038/s43018-023-00614-y